Aaron Fountain > DLA Piper LLP (US) > Austin, United States > Lawyer Profile

DLA Piper LLP (US)
401 CONGRESS AVENUE
SUITE 2500
AUSTIN,TEXAS 78701-3799
United States
Aaron Fountain photo

Work Department

Intellectutal Property and Technology; Litigatin, Arbitration and Investigations; Patent Litigation; Patent Prosecution and Strategic Patent Counseling; Technology; Life Sciences

Position

Partner

Career

Aaron Fountain concentrates his practice on patent litigation and other intellectual property related matters. Aaron has extensive experience representing clients in dozens of patent infringement matters in the Eastern District of Texas and the District of Delaware.

Aaron has also represented clients before the USPTO, including inter partes review proceedings before the Patent Trial and Appeal Board and providing strategic patent portfolio management advice. 

His clients span a range of technologies, including molecular diagnostics, topical pharmaceuticals, telecom infrastructure, set top boxes, oil field services and all manner of software.

Education

J.D., University of Houston Law Center; B.S., Pepperdine University

Lawyer Rankings

United States > Industry focus > Healthcare: life sciences

Co-heads of DLA Piper LLP (US)‘s practice, San Diego-based Lisa Haile and Matthew Holian in Boston, specialize in patentability and licensing strategies, and product liability and mass tort, respectively. Recent highlights include obtaining issuance of multiple patents for Aegis Therapeutics’ key product areas and assisting Pfizer and Bristol-Myers Squibb (BMS) with multidistrict and state court litigation concerning alleged defects of the clients’ blockbuster anticoagulant medication Eliquis. New York-based litigator Loren Brown has been acting for Medtronic and Covidien in product liability litigation related to complications allegedly caused by some of Covidien’s implantable hernia mesh products. San Diego’s Larry Nishnick and Austin’s Aaron Fountain are names to note for corporate investment and patent litigation respectively.